← Back to news
Y

Yahoo Finance

Volatile Avis stock plunges on wider-than-expected profit loss

Y

Is Upstart Stock a Buy After Hedge Fund Halter Ferguson Purchased Shares Worth $37 Million?

Y

4 Things Every Vanguard S&P 500 ETF Investor Needs to Know

Y

Italian regulator fines snacks “cartel”

Y

Robinhood misses Q1 revenue estimates as crypto trading slumps

Y

A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors.

Y

Hong Kong Sees Rise Of Fake Stablecoins

Y

Ripple (XRP) News: OKX’s RLUSD Listing Just Made the Stablecoin Institutional Collateral

Y

Applied Materials At 42x: Boom Or Bubble?

Y

How to refinance a car loan with bad credit

Y

UPS to close 27 additional parcel facilities in 2026

Y

Humana Q1 2026 earnings beat estimates, stock falls

Y

Amazon Earnings Preview: AI Momentum In Focus, But This Number Could Be 'Messy'

Y

T-Mobile Shoots Down Cable TV Acquisition On Q1 Earnings Call

Y

Verizon Communications vs. AT&T: What's the Better Dividend Stock to Buy Right Now?

Y

Avis Plummets 12%, Hertz Drops 5% – What’s Going On With Car Rental Stocks?

Y

Mondelez “cautiously optimistic” as outlook rests on consumer uncertainty

Y

John Fetterman's Micron Stock Bet Surges 61%, Notes Popular Nancy Pelosi Tracker: 'This Is Suspect'

Y

Starbucks Leads Seven Stocks Flashing Buy Signals On Earnings

Y

Visa earnings top estimates on strong spending, shares rise

Y

KKR & Co. (KKR) Falls on Earnings Miss Despite Strong Fundraising Momentum and Long-Term Growth Plans

Y

The freight brokerage model broke carrier selection

Y

Kone agrees to buy TK Elevator for $34.4 billion

Y

Silicon Motion Stock Rockets As Sales More Than Double

Y

Galaxy Digital Leads Investment In Blockchain Startup Fence

Y

Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide

Y

What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in

Y

Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial

Y

H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)

Y

Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why

Y

Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data

Y

Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at

Y

Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?

Y

In A Victory, Gemini Put In Four Million GM Cars

Y

AbbVie beats Q1 2026 earnings, raises full-year forecast

Y

Ex-Mars CEO named Lipton chair

Y

Robinhood's crypto revenue tanks 47%, gap filled by prediction markets

Y

Regeneron Slumps On An Unexpected Setback For Its Bread-And-Butter Drug

Y

Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results

Y

Seagate Stock Soars After AI Demand Powers Big Earnings Beat

Y

Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight

Y

Treasury Yields Keep Rising as Oil Prices Spur Inflation Fears

Y

Should You Be Bullish on Natera (NTRA)?

Y

Why data storage stocks are a key AI play

Y

Fed meeting today: Central bank 'firmly parked' on interest rate pause

Y

Teva Surges 10% — And It's Not Completely Tied To Earnings

Y

'Did I save too much?': Your 401(k) may be at all-time highs, but big balances carry hidden retirement risks

Y

Meta Earnings Preview: AI 'Monetization Story' Faces Biggest Test Yet

Y

Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1

Y

Daily – Vickers Top Buyers & Sellers for 04/29/2026

Y